In brief, if we screen younger men, require secondary tests before biopsy (MRI or marker), only treat men with aggressive disease (ie active surveillance for low risk), & regionalize treatment at hi-volume centers, PSA screening will do more good than harm.

My golf ball probably around there somewhere